Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
Rheinmetall AG €1,650.0 €2,100.0
NVIDIA Corp. €159.00 €201.17
Siemens Energy AG €157.15 €180.00
Security Price Target price
HP Inc. €16.15 €17.11
Factset Research Systems €182.35 €177.53
BlackRock TCP Capital Corp. €3.28 €2.98

Many tell you which stocks to buy.

We measure how often they are right!

Portfolios of our members

1/7DerAlmanach100000
Total
€211,121
Cash
€17,527
Performance (%)
111.128%

Pros and Cons of these stocks (New Predictions)

CrowdStrike Holdings Inc

WKN: A2PK2R / Symbol: CRWD / Name: CrowdStrike / Stock / Software & IT Services / Large Cap /

Pros
3
Very good company culture
3
Growths much faster than the competition
4
Market Leader or Top 3
Cons
Quantum Corp.

WKN: A40M9N / Name: Quantum Corp. / Stock / ? /

Pros
2
Undervalued
2
Very capable Management
5
Could be worthwhile Investment >10% per year
Cons
2
Few uniques
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops S&P 500

Security Price Change(%) (%)
Corning Inc. €118.96 5.590%
Micron Technology Inc. €352.60 5.490%
Discovery Communications C €22.42 5.110%
Western Digital Corp. €235.30 4.970%
Under Armour Inc. A €5.83 4.770%
Security Price Change(%) (%)
Centene Corp. €32.04 -14.100%
United Rentals Inc. €662.80 -6.230%
Ipg Photonics €98.96 -5.750%
Paycom Software €112.85 -5.290%
Gartner Inc. €136.00 -5.160%

Courses

Key figures for stocks: https://unsplash.com/@markusspiske?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText
Key figures for stocks
Keeping an eye on the various key figures is important. We tell you what they mean.
Get started on the stock market in these easy steps
This course is directed at beginners who want to get started on the stock market.

Things you will learn:
  •  What is a stock
  •  What is a fund
  •  What is an ETF
  •  How to open a depot
  •  How to manage a depot that will regularly beat managed funds
  •  Why you mostly need patience to succeed on the stock market

Predictions

buy
Hyatt Hotels A

Start price
Target price
Perf. (%)
€133.80
19:00
€159.14
10.03.27
-
12:28

buy
Hilton Inc.

Start price
Target price
Perf. (%)
€257.10
19:00
€260.64
10.03.27
-
17:21

Choice Hotels Internatl.

Start price
Target price
Perf. (%)
€84.50
18:30
€71.40
10.03.27
-
08:48

buy
Marriott International Inc.

Start price
Target price
Perf. (%)
€282.45
18:30
€284.73
10.03.27
0.00%
18:46

Top News

News

Applied Optoelectronics: After a 700% Run, Can Execution Keep Up?
Applied Optoelectronics: After a 700% Run, Can Execution Keep Up?

Applied Optoelectronics AAOI has already delivered the kind of move that forces investors to raise their standards. The stock is up 241.4% in the past three months and 722.8% over the past year

Amazon Trades at a Premium P/E: Time to Hold or Fold the Stock?
Amazon Trades at a Premium P/E: Time to Hold or Fold the Stock?

Amazon.com AMZN delivered a strong operational finish to 2025, posting record quarterly revenues and accelerating cloud growth, yet the stock has struggled to build on that momentum. The company’s

VRTX Stock Gains on Upbeat Interim Data From Kidney Disease Drug Study
VRTX Stock Gains on Upbeat Interim Data From Kidney Disease Drug Study

Vertex Pharmaceuticals VRTX announced positive data from an interim analysis of the ongoing phase III RAINER study, which evaluated its investigational drug povetacicept for IgA nephropathy (IgAN)

Why Petco (WOOF) is Poised to Beat Earnings Estimates Again
Why Petco (WOOF) is Poised to Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Petco Health & Wellness (WOOF), which

Why Five Below (FIVE) is Poised to Beat Earnings Estimates Again
Why Five Below (FIVE) is Poised to Beat Earnings Estimates Again

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Five Below

All You Need to Know About Teads Holding Co. (TEAD) Rating Upgrade to Buy
All You Need to Know About Teads Holding Co. (TEAD) Rating Upgrade to Buy

Teads Holding Co. (TEAD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of

TSMC (TSM) Upgraded to Strong Buy: Here's What You Should Know
TSMC (TSM) Upgraded to Strong Buy: Here's What You Should Know

TSMC (TSM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one

Lumen (LUMN) Upgraded to Strong Buy: What Does It Mean for the Stock?
Lumen (LUMN) Upgraded to Strong Buy: What Does It Mean for the Stock?

Lumen (LUMN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one

Regency Centers (REG) Upgraded to Buy: Here's Why
Regency Centers (REG) Upgraded to Buy: Here's Why

Regency Centers (REG) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of

Contest

Compete in Catch the Monkey ...

... and win a prize!

Heibel Ticker

sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.

Kostenlos ausprobieren

Leeway

Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren